Cullgen Appoints Dr. Mark Deeg to Lead Clinical Development,

At Eli Lilly, he conducted early phase clinical trials and oversaw the biomarker strategy for Lilly’s endocrine portfolio. He later served as the Chief Medical …, At Eli Lilly, he conducted early phase clinical trials and oversaw the biomarker strategy for Lilly’s endocrine portfolio. He later served as the Chief Medical …, Read More

Scroll to Top